無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の生体吸収性冠状動脈ステント市場の分析と予測:ブランド(Absorb BVS、第二世代Absorb、Magmaris、Magnitude、MeRes-100、DE Solve)、地域別 2016年〜2025年

Bioresorbable Coronary Stents Market Analysis By Brand Outlook (Absorb BVS, Absorb 2nd Generation, Magmaris, Magnitude, MeRes-100, DESolve), By Region, And Segment Forecasts, 2016 - 2025

発行 Grand View Research, Inc. 商品コード 600822
出版日 ページ情報 英文 77 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=111.44円で換算しております。
Back to Top
世界の生体吸収性冠状動脈ステント市場の分析と予測:ブランド(Absorb BVS、第二世代Absorb、Magmaris、Magnitude、MeRes-100、DE Solve)、地域別 2016年〜2025年 Bioresorbable Coronary Stents Market Analysis By Brand Outlook (Absorb BVS, Absorb 2nd Generation, Magmaris, Magnitude, MeRes-100, DESolve), By Region, And Segment Forecasts, 2016 - 2025
出版日: 2017年11月14日 ページ情報: 英文 77 Pages
概要

生体吸収性ステントは、吸収された後、血管の機能が自然な形で回復することから、主に若年成人を対象に使用されています。世界の生体吸収性ステント市場は、2025年までに2億4700万米ドルの収入の増加が見込まれています。

当レポートでは、世界の生体吸収性冠動脈ステント市場について調査し、市場の概要、ブランド・地域別の市場動向、市場規模の推移と予測、市場成長要因の分析、市場シェア、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 調査方法と範囲

  • 情報調達
  • 調査方法
  • 市場の見通しと前提条件
  • 市場算定:地域別
  • 市場シェア:地域別
  • 2次情報源のリスト

第2章 エグゼクティブサマリー

  • 市場概要

第3章 世界の生体吸収性冠動脈ステント市場の動向と範囲

  • 市場区分と範囲
  • 浸透と成長の見通しマッピング
  • SWOT分析
  • 産業分析 - ファイブフォース分析

第4章 世界の生体吸収性冠動脈ステント市場の動向分析と予測:ブランド別

  • ブランド分析
  • 市場動向の分析:ブランド別

第5章 世界の生体吸収性冠動脈ステント市場の動向分析と予測:地域別

  • 市場シェア:地域別
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
  • アジア太平洋地域
    • 日本
    • インド

第6章 競合情勢

  • 戦略の枠組み
  • 参入企業の分類
  • 企業プロファイル

第7章 臨床パイプラインの概要

  • Amaranth Medical
  • Microport Scientific Corporation
  • Arterius
目次
Product Code: GVR-2-68038-234-1

Anticipated as well as recently launched global bioresorbable coronary stents market will trigger a revenue increase to USD 247 million by 2025. According to a new report by Grand View Research, Inc., better device attributes of second-generation coronary stents will provide the ascending push to this market.

Bioresorbable stents are intended majorly for the young adult population, whereby these individuals are enabled with a normal functioning artery following complete resorption of the dissolvable devices.Lifestyle diseases and prevalence of associated risk factors underpin the growth in atherosclerosis-related cardiac events. This drives the global disease prevalence in young adults as well as the high volume of elective Percutaneous Coronary Interventions (PCI).

What sets the second-generation bioresorbable coronary stents apart? - Learning from past mistakes, manufacturers have developed new generation bioresorbable with thinner strut thicknesses, faster resorption times, and better radial force. Amaranth, with a single-minded focus on strut thickness, has developed three such devices. Each with a thinner strut. The latest, Magnitude boasts of 100 microns.

Another factor providing a fillip to this market is the less-invasive nature of PCIs as compared to coronary artery bypass grafting, resulting in their high elective procedure volume. In most parts of the world, lack of auditing to check inappropriate surgeries drives the number of coronary stenting procedures. Hence, this market is expected to witness growth due to the high volume of elective PCI, particularly in APAC and Europe.

Further Key Findings From the Study Suggest:

  • Europe region is the major contributor for the bioresorbable stents market in 2016. Subsequent to withdrawal of the bioresorbable Absorb BVS, emergence of CE-approved bioresorbable stents hold strong growth prospects for greater sales in the member countries.
  • APAC follows Europe with almost 30% segment share and is expected to record the fastest growth in the future
  • Absorb BVS, among the key brands, engendered the highest sales revenue in 2016, while Absorb 2nd generation device will supersede the sales of its rival devices toward the end of the forecast period
  • North America trails behind as the smallest revenue generator against leading counterparts, Europe and APAC, in this market. Downfall of Abbott's Absorb BVS, the only approved FDA device, is the underlying reason for the small segment share in the U.S. region.
  • Key players in this space include BIOTRONIK, Meril Lifesciences Pvt. Ltd., Abbott, Elixir Medical Corporation, REVA Medical, Arterial Remodeling Technologies, and Amaranth Medical
  • Strategic efforts undertaken by the companies to gain a higher market share center on bioresorbable coronary stents development. Companies targeting the clinical pipeline have developed second-generation bioresorbable products with better design specifications, such as devices with thinner strut thicknesses and faster absorption rates that gain comparability with the gold standard, drug-eluting metallic stents.

Table of Contents

Chapter 1 Research Methodology & Scope

  • 1.1 Information Procurement
    • 1.1.1 Purchased database:
    • 1.1.2 GVR's internal database
  • 1.2 Research Methodology
  • 1.3 Geographic Scope & Assumptions
  • 1.4 Region-wise market calculation
    • 1.4.1 Region-wise market: Base estimates
    • 1.4.2 Global market: CAGR calculation
  • 1.5 Region-based Segment Share Calculation
  • 1.6 List of Secondary Sources

Chapter 2 Executive Summary

  • 2.1 Market Snapshot

Chapter 3 Bioresorbable Coronary Stents Market Variables, Trends & Scope

  • 3.1 Market Segmentation & Scope
    • 3.1.1 Market Driver Analysis
      • 3.1.1.1 High disease prevalence in young adults
      • 3.1.1.2 High Elective PCI Volume
    • 3.1.2 Market restraint analysis
      • 3.1.2.1 Slow pace of the market: Lack of adequate clinical trial results
      • 3.1.2.2 Low comparability of bioresorbable coronary stents to DES
  • 3.2 Penetration & Growth Prospect Mapping
  • 3.3 Bioresorbable Coronary Stents Market- SWOT Analysis, By Factor (political & legal, economic and technological)
  • 3.4 Industry Analysis - Porter's

Chapter 4 Bioresorbable Coronary Stents Market: Brand Outlook, Estimates & Trend Analysis

  • 4.1 Bioresorbable Coronary Stents Market: Brand analysis
  • 4.2 Bioresorbable Coronary Stents Market: Brand movement analysis
    • 4.2.1 Absorb BVS, 2016 - 2025 (USD Million)
    • 4.2.2 Absorb 2nd Generation, 2016 - 2025 (USD Million)
    • 4.2.3 Magmaris, 2016 - 2025 (USD Million)
    • 4.2.4 Magnitude, 2016 - 2025 (USD Million)
    • 4.2.5 MeRes-100, 2016 - 2025 (USD Million)
    • 4.2.6 DESolve, 2016 - 2025 (USD Million)

Chapter 5 Bioresorbable Coronary Stents Market: Regional Estimates & Trend Analysis

  • 5.1 Bioresorbable Coronary Stents Market share, by region, 2016 & 2024
  • 5.2 North America
    • 5.2.1 North America Bioresorbable Coronary Stents Market, 2016 - 2025 (USD Million)
    • 5.2.2 U.S.
      • 5.2.2.1 U.S. Bioresorbable Coronary Stents Market, 2016 - 2025 (USD Million)
    • 5.2.3 Canada
      • 5.2.3.1 Canada Bioresorbable Coronary Stents Market, 2016 - 2025 (USD Million)
  • 5.3 Europe
    • 5.3.1 Europe Bioresorbable Coronary Stents Market, 2016 - 2025 (USD Million)
    • 5.3.2 UK
      • 5.3.2.1 UK Bioresorbable Coronary Stents Market, 2016 - 2025 (USD Million)
    • 5.3.3 Germany
      • 5.3.3.1 Germany Bioresorbable Coronary Stents Market, 2016 - 2025 (USD Million)
    • 5.3.4 France
      • 5.3.4.1 France Bioresorbable Coronary Stents Market, 2016 - 2025 (USD Million)
    • 5.3.5 Italy
      • 5.3.5.1 Italy Bioresorbable Coronary Stents Market, 2016 - 2025 (USD Million)
    • 5.3.6 Spain
      • 5.3.6.1 Spain Bioresorbable Coronary Stents Market, 2016 - 2025 (USD Million)
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Bioresorbable Coronary Stents Market, 2016 - 2025 (USD Million)
    • 5.4.2 Japan
      • 5.4.2.1 Japan Bioresorbable Coronary Stents Market, 2016 - 2025 (USD Million)
    • 5.4.3 India
      • 5.4.3.1 India Bioresorbable Coronary Stents Market, 2016 - 2025 (USD Million)

Chapter 6 Competitive Landscape

  • 6.1 Strategy Framework
  • 6.2 Market Participation Categorization
  • 6.3 Company Profiles
    • 6.3.1 Biotronik
      • 6.3.1.1 Company overview
      • 6.3.1.2 Product overview
      • 6.3.1.3 Business Strategies
    • 6.3.2 Meril Lifesciences Pvt. Ltd.
      • 6.3.2.1 Company overview
      • 6.3.2.2 Product overview
      • 6.3.2.3 Business Strategies
    • 6.3.3 Abbott
      • 6.3.3.1 Company overview
      • 6.3.3.2 Product overview
      • 6.3.3.3 Business Strategies
    • 6.3.4 Elixir Medical Corporation
      • 6.3.4.1 Company overview
      • 6.3.4.2 Product overview
      • 6.3.4.3 Business Strategies
    • 6.3.5 REVA Medical
      • 6.3.5.1 Company overview
      • 6.3.5.2 Product overview
      • 6.3.5.3 Business Strategies
    • 6.3.6 Arterial Remodeling Technologies
      • 6.3.6.1 Company overview
      • 6.3.6.2 Product overview
      • 6.3.6.3 Business Strategies

Chapter 7 Clinical Pipeline Overview

  • 7.1 Amaranth Medical
    • 7.1.1 Company overview
    • 7.1.2 Pipeline products
    • 7.1.3 Clinical Trials
  • 7.2 Microport Scientific Corporation
    • 7.2.1 Company overview
    • 7.2.2 Pipeline products
    • 7.2.3 Clinical Trials
  • 7.3 Arterius
    • 7.3.1 Company overview
    • 7.3.2 Pipeline Products
    • 7.3.3 Clinical Trials

List of Tables

  • TABLE 1 Country share estimation
  • TABLE 2 North America bioresorbable coronary stents market estimates and forecasts, by brand outlook, 2016 - 2025 (USD Million)
  • TABLE 3 U.S bioresorbable coronary stents market estimates and forecasts, by brand outlook, 2016 - 2025 (USD Million)
  • TABLE 4 Canada bioresorbable coronary stents market estimates and forecasts, by brand outlook, 2016 - 2025 (USD Million)
  • TABLE 5 Europe bioresorbable coronary stents market estimates and forecasts, by brand outlook, 2016 - 2025 (USD Million)
  • TABLE 6 UK bioresorbable coronary stents market estimates and forecasts, by brand outlook, 2016 - 2025 (USD Million)
  • TABLE 7 Germany bioresorbable coronary stents market estimates and forecasts, by brand outlook, 2016 - 2025 (USD Million)
  • TABLE 8 Asia Pacific bioresorbable coronary stents market estimates and forecasts, by brand outlook, 2016 - 2025 (USD Million)
  • TABLE 9 Japan bioresorbable coronary stents market estimates and forecasts, by brand outlook, 2016 - 2025 (USD Million)
  • TABLE 10 India bioresorbable coronary stents market estimates and forecasts, by brand outlook, 2016 - 2025 (USD Million)
  • TABLE 11 List of Market Players

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Value chain-based sizing & forecasting
  • FIG. 4 QFD modeling for market share assessment
  • FIG. 5 Market summary
  • FIG. 6 Market trends & outlook
  • FIG. 7 Market segmentation & scope
  • FIG. 8 Market driver relevance analysis (Current & future impact)
  • FIG. 9 Global percentage of stroke occurrence, by age group
  • FIG. 10 Market restraint relevance analysis (Current & future impact)
  • FIG. 11 Penetration & growth prospect mapping
  • FIG. 12 SWOT Analysis, By Factor (political & legal, economic and technological)
  • FIG. 13 Porter's Five Forces Analysis
  • FIG. 14 Bioresorbable coronary stents market type outlook: key takeaways
  • FIG. 15 Bioresorbable coronary stents market: Type movement analysis
  • FIG. 16 Brand Outlook, 2016 - 2025 (USD Million)
  • FIG. 17 Regional market place: Key takeaways
  • FIG. 18 Regional outlook, 2016 & 2024
  • FIG. 19 North America bioresorbable coronary stents market, 2016 - 2025 (USD Million)
  • FIG. 20 U.S. bioresorbable coronary stents market, 2016 - 2025 (USD Million)
  • FIG. 21 Canada bioresorbable coronary stents market, 2016 - 2025 (USD Million)
  • FIG. 22 Europe bioresorbable coronary stents market, 2016 - 2025 (USD Million)
  • FIG. 23 UK bioresorbable coronary stents market, 2016 - 2025 (USD Million)
  • FIG. 24 Germany bioresorbable coronary stents market, 2016 - 2025 (USD Million)
  • FIG. 25 France bioresorbable coronary stents market, 2016 - 2025 (USD Million)
  • FIG. 26 Italy bioresorbable coronary stents market, 2016 - 2025 (USD Million)
  • FIG. 27 Spain bioresorbable coronary stents market, 2016 - 2025 (USD Million)
  • FIG. 28 Asia Pacific bioresorbable coronary stents market, 2016 - 2025 (USD Million)
  • FIG. 29 Japan bioresorbable coronary stents market, 2016 - 2025 (USD Million)
  • FIG. 30 India bioresorbable coronary stents market, 2016 - 2025 (USD Million)
  • FIG. 31 Strategy framework
  • FIG. 32 Participant categorization
Back to Top